This specialized program at Maine Medical Center has a focus in primary care with unique specialty opportunities focused in transitions of care, anticoagulation, transplantation, neurology, virology, outpatient oncology, care for the underserved, academia and more. The Ambulatory Care Pharmacy Resident also has the opportunity to participate in didactic and experiential teaching in collaboration with the University of New England's College of Pharmacy. Upon completion of the program, residents should possess skills that support advanced clinical practice within an interdisciplinary healthcare team, as well as faculty positions and eligibility for board certification in Ambulatory Care Pharmacy.
The purpose of the Maine Medical Center PGY2 Critical Care Pharmacy Residency program is to prepare a specialty practitioner who is qualified to act independently to meet the needs of medical, surgical, cardiac, and neuroscience critical care patients, offer educational experiences to others, perform research, and achieve board certification through the development of accountability, practice patterns, habits and approaches using attained expert knowledge and skill. Graduates of the MMC PGY2 Critical Care Pharmacy Residency should be prepared to pursue employment as a critical care pharmacotherapy specialist in a clinical practice position. Positions could include practice in a hospital-based environment or a combination of academia and hospital-based practice affiliated with a College of Pharmacy.
Rotational experiences include: inpatient pharmacotherapy management of acute infectious diseases, microbiology, hospital/institutional epidemiology, antimicrobial stewardship activities/committees/initiatives, educational opportunities to fellow pharmacists and other healthcare providers, and completion of an infectious diseases-related research project. Additionally, residents will have the opportunity to gain experience in the management of outpatient infectious diseases such as HIV and HCV.
This advanced program at MMC has a focus on adult and pediatric patients with cancer, with an emphasis on supportive care, antineoplastic pharmacology, management of malignant and hematological disorders, investigational cancer therapies, and antineoplastic toxicity management. Graduates from the program will be equipped to serve as integral members of interdisciplinary teams caring for individuals with cancers in both inpatient and outpatient settings.